DENVER — Heart disease in young people is certainly possible. Supraventricular tachycardia (SVT) can affect kids, adolescents and young adults. It occurs in about 2 out of every 1,000 people. SVT ...

Catheter ablation was not the first-line treatment for supraventricular tachycardia (SVT) for most patients referred to a tertiary center, a study shows, with investigators suggesting the procedure is ...

Exposure to air pollution is associated with the onset of symptomatic arrhythmia within a few hours, new data indicate. "Our study provides novel evidence that hourly exposures to air pollutants may ...

(RTTNews) - Milestone Pharmaceuticals Inc. (MIST) has received FDA approval for its first commercial product, CARDAMYST nasal spray, for the conversion of acute symptomatic episodes of paroxysmal ...

First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly resolve episodes of PSVT and restore sinus rhythm FDA approval in PSVT ...

Atrioventricular (AV) nodal reentrant tachycardia (AVNRT) is an irregular heart rhythm that can cause excessively fast heart rates. Though not usually serious, early diagnosis can help prevent severe ...

CARDAMYST nasal spray is a novel and rapid-acting calcium channel blocker delivered when needed to treat often highly symptomatic and unpredictable episodes of PSVT. With CARDAMYST, adults with PSVT ...